<DOC>
	<DOCNO>NCT00919425</DOCNO>
	<brief_summary>RATIONALE : Collecting store sample blood bone marrow patient cancer study laboratory may help doctor learn diagnose cancer well patient respond treatment . PURPOSE : The purpose study collect store blood bone marrow sample patient hematologic cancer test laboratory .</brief_summary>
	<brief_title>S9910 , Collecting Storing Blood Bone Marrow Samples From Patients With Hematologic Cancer</brief_title>
	<detailed_description>Primary objective : - Maintain expand tissue repository highly characterized sample patient acute lymphoblastic leukemia , chronic lymphocytic leukemia , acute myeloid leukemia , chronic myelogenous leukemia , myelodysplastic syndrome . Other objective fund permit : - Develop laboratory assay rapid precise diagnosis leukemia use bone marrow peripheral blood sample . - Determine biologic , genetic , molecular parameter distinguish different subtypes human leukemia differ response therapy , develop `` risk-adapted '' therapeutic approach base parameter tailor therapeutic regimen , randomize stratify patient clinical trial , otherwise assist therapeutic decision-making . - Develop new automate standardized laboratory method detection monitoring therapeutic responsiveness minimal residual disease patient use information design clinical trial . OUTLINE : Patients receive treatment direct Southwest Oncology Group ( SWOG ) study register . Patients undergo collection peripheral blood ( myeloid leukemia ) venous blood ( lymphoid leukemia ) bone marrow baseline , time response remission , time progression relapse . Additional collection may take place accord guideline study patient register . Specimens store use laboratory research . PROJECTED ACCRUAL : Samples maximum 1,000 patient collect study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<mesh_term>Myelodysplastic-Myeloproliferative Diseases</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Currently register Southwest Oncology Group ( SWOG ) treatment study acute lymphoblastic leukemia , chronic lymphocytic leukemia , acute myeloid leukemia , chronic myelogenous leukemia , myelodysplastic syndrome PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>stage 0 chronic lymphocytic leukemia</keyword>
	<keyword>stage I chronic lymphocytic leukemia</keyword>
	<keyword>stage II chronic lymphocytic leukemia</keyword>
	<keyword>stage III chronic lymphocytic leukemia</keyword>
	<keyword>stage IV chronic lymphocytic leukemia</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>relapse chronic myelogenous leukemia</keyword>
	<keyword>refractory chronic lymphocytic leukemia</keyword>
	<keyword>chronic phase chronic myelogenous leukemia</keyword>
	<keyword>accelerated phase chronic myelogenous leukemia</keyword>
	<keyword>blastic phase chronic myelogenous leukemia</keyword>
	<keyword>meningeal chronic myelogenous leukemia</keyword>
	<keyword>untreated adult acute lymphoblastic leukemia</keyword>
	<keyword>untreated adult acute myeloid leukemia</keyword>
	<keyword>adult acute myeloid leukemia ( 8 ; 21 ) ( q22 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 16 ; 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia inv ( 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia 11q23 ( MLL ) abnormality</keyword>
	<keyword>adult acute myeloid leukemia ( 15 ; 17 ) ( q22 ; q12 )</keyword>
	<keyword>adult acute lymphoblastic leukemia remission</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>adult acute myeloid leukemia remission</keyword>
	<keyword>childhood acute myeloid leukemia remission</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>untreated childhood acute myeloid leukemia myeloid malignancy</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>untreated childhood acute lymphoblastic leukemia</keyword>
	<keyword>childhood chronic myelogenous leukemia</keyword>
	<keyword>de novo myelodysplastic syndrome</keyword>
	<keyword>previously treat myelodysplastic syndrome</keyword>
	<keyword>secondary myelodysplastic syndrome</keyword>
	<keyword>secondary acute myeloid leukemia</keyword>
	<keyword>atypical chronic myeloid leukemia , BCR-ABL1 negative</keyword>
	<keyword>chronic myelomonocytic leukemia</keyword>
	<keyword>juvenile myelomonocytic leukemia</keyword>
	<keyword>myelodysplastic/myeloproliferative neoplasm , unclassifiable</keyword>
	<keyword>childhood myelodysplastic syndrome</keyword>
</DOC>